Gabapentin
Product Images NDC 67046-227

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 67046-227). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Gabapentin (33b9c9ba F71c 49f9 9bfc F0d8a68aeab6 01)

FDA Label Image

Figure 1 (33b9c9ba F71c 49f9 9bfc F0d8a68aeab6 02)

FDA Label Image

Figure 2 (33b9c9ba F71c 49f9 9bfc F0d8a68aeab6 03)

This appears to be a chart or graph with headings for "mean pain score", "Wask Dosa TirstionPatad", "Wask Fxsa Do Parod", and doses of medication (Gabapentin at 1890 mg/day and 2490 mg/day). However, without more context or a clearer image, it is not possible to provide a useful description.*

FDA Label Image

Figure 3 (33b9c9ba F71c 49f9 9bfc F0d8a68aeab6 04)

FDA Label Image

Figure 4 (33b9c9ba F71c 49f9 9bfc F0d8a68aeab6 05)

FDA Label Image

Table 2 (33b9c9ba F71c 49f9 9bfc F0d8a68aeab6 06)

This appears to be a table comparing the adverse effects of Gabapentin tablets and Placebo in a clinical trial. The table details the number of patients who experienced various symptoms related to different body systems affected by the medication or placebo. The adverse effects are categorized in multiple systems including Body, Digestive, Metabolic and Nutritional disorders, Skin and Appendages, and Special Senses. Some common adverse effects include Asthenia, Infection, Diarrhea, Peripheral edema, Dizziness, and Somnolence. There is also a reported case of blurred vision.*

FDA Label Image

Table 3 (33b9c9ba F71c 49f9 9bfc F0d8a68aeab6 07)

This is a list of adverse events experienced by patients taking Gabapentin tablets. The adverse events affect different parts of the body, such as the nervous system, musculoskeletal system, digestive system, respiratory system, and skin and appendages. Some of the adverse events reported include fatigue, weight increase, back pain, peripheral edema, dyspepsia, dental abnormalities, myalgia, somnolence, dizziness, ataxia, nervousness, dysathria, amnesia, depression, rhinitis, pharyngitis, coughing, impotence, diplopia, and reduced white blood cell count. Additionally, the report mentions that the drug may cause amblyopia, a condition that causes blurred vision. The results were obtained under the condition of background antiepileptic drug therapy.*

FDA Label Image

Table 4 (33b9c9ba F71c 49f9 9bfc F0d8a68aeab6 08)

This appears to be a table comparing the incidence of adverse events for Gabapentin tablets versus a placebo in a clinical trial with 128 participants. The adverse events are listed by body system, including viral infection, fever, weight increase, fatigue, nausea/vomiting, and various neurological symptoms such as somnolence, hostility, emotional lability, dizziness, and hyperkinesia. The use of Gabapentin tablets was in addition to existing antiepileptic drug therapy.*

FDA Label Image

Table 5 (33b9c9ba F71c 49f9 9bfc F0d8a68aeab6 09)

This text provides information on renal function and suggested dose range for medications based on creatinine clearance. It also includes a supplemental post-hemodialysis dose for patients on hemodialysis. For patients with a creatinine clearance less than 15 mL/min, the daily dose should be reduced in proportion to their clearance.*

FDA Label Image

Glenmark Logo (33b9c9ba F71c 49f9 9bfc F0d8a68aeab6 10)

FDA Label Image

Blister Of 30 Tablets (33b9c9ba F71c 49f9 9bfc F0d8a68aeab6 11)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.